Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Schwann cell proliferation and differentiation that is induced by ferulic acid through MEK1/ERK1/2 signalling promotes peripheral nerve remyelination following crush injury in rats.
[Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in Galicia].
A new assessment tool for patients with multiple sclerosis from Spanish-speaking countries: validation of the Brief International Cognitive Assessment for MS (BICAMS) in Argentina.
Structural brain anomalies in healthy adolescents in the NCANDA cohort: relation to neuropsychological test performance, sex, and ethnicity.
Can we stop immunomodulatory treatments in secondary progressive multiple sclerosis?
Down-regulation of CYP27B1 gene expression in Iranian patients with relapsing-remitting multiple sclerosis.
A Risk Score for Predicting Multiple Sclerosis.
Integrated multidisciplinary clinics should be the gold standard in managing progressive MS - YES.
Vitamin D and Systemic Lupus Erythematosus: Myth or Reality?
Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial.
Disability progression in aggressive multiple sclerosis.
The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study.
Assessment of vitamin D status - a changing landscape.
Vibration Training Improves Disability Status Among Individuals With Multiple Sclerosis: 1477 Board #130 June 2, 9: 00 AM - 10: 30 AM.
[Cell depletion and myoablation for neuroimmunological diseases].
Cytokine Therapies in Neurological Disease.
Diffuse Brain Hypoperfusion in Advanced Leukoencephalopathy with Calcifications and Cysts.
Cystine/glutamate antiporter blockage induces myelin degeneration.
Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial.
Weighing Evidence from Mendelian Randomization-Early-Life Obesity as a Causal Factor in Multiple Sclerosis?
Proteolytic processing of Neuregulin-1.
TIM-3 Rs10515746 (A/C) and Rs10053538 (C/A) Gene Polymorphisms and Risk of Multiple Sclerosis.
Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy.
Combined effects of transferrin and thyroid hormone during oligodendrogenesis In vitro.
Natalizumab: a new therapy for acute ischemic stroke?

Pages